NVO
Stock Details
NVO is Novo Nordisk A/S's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 130.33$. Average daily volumn in 3 months 1.41M. Market cap 310.58B
Stock symbol : NVO. Exchange : NYSE. Currency : USD Lastest price : 138.09$. Total volume : 1.10M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Novo Nordisk A/S (NVO)
Last Price
138.09$Change
0.55Volume
1.10M
| Previous Close | 137.54 |
| Open | 137.95 |
| Day Range | 137.57-138.81 |
| Bid | 0.00 x 1k |
| Ask | 0.00 x 1.3k |
| Volume | 1.1M |
| Average Volume | 1.41M |
| Market Cap | 310.58B |
| Beta | 0.35 |
| 52 Week Range | 94.75-144.78 |
| Trailing P/E | 40.61 |
| Foward P/E | 31.97 |
| Dividend (Yield %) | 1.16% |
| Ex-Dividend Date | 2022-08-12 |
Financial Details
Organization
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormon... e replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Market Cap:
310.58BRevenue:
140.8BTotal Assets:
194.51BTotal Cash:
10.72B
News about "Novo Nordisk A/S"
Is a Beat on the Cards for Novo Nordisk (NVO) in Q4 Earnings?
Source from : YAHOO!Finance - 2 days ago
Novo Nordisk's (NVO) top line is likely to have been driven by sales of its Diabetes and Obesity Care products in the fourth quarter of 2022.See details»
Novo Nordisk A/S Class B (NOVOb)
Source from : Investing - 2 days ago
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»
Novo Nordisk A/S Series B
Source from : Wall Street Journal - 5 days ago
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...See details»
Novo Nordisk A/S – Share repurchase programme
Source from : Yahoo Finance - 5 days ago
Bagsværd, Denmark, 23 January 2023 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...See details»
Do You Think Novo Nordisk A/S (NVO) is an Economically Sensitive Stock?
Source from : Insider Monkey - 15 days ago
Mawer Investment Management highlighted stocks like Novo Nordisk A/S (NYSE:NVO) in the fourth quarter investor letter. Headquartered in Bagsvaerd, Denmark, Novo Nordisk A/S (NYSE:NVO) is a ...See details»
Novo Nordisk A/S (NVO) and the Battle of Fundamentals vs. Technicals
Source from : newsheater - 9 days ago
Novo Nordisk A/S (NYSE:NVO) went up by 0.64% from its latest closing price compared to the recent 1-year high of $140.95. The company’s stock price has collected 6.09% of gains in the last five ...See details»
Novo Nordisk A/S:
Source from : Yahoo News - 1 month ago
Bagsværd, Denmark, 22 December 2022 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and ...See details»
Highlights from the Ratings and Financial Report for Novo Nordisk A/S (NVO)
Source from : newsheater - 2 years ago
Novo Nordisk A/S (NYSE:NVO) went down by -0.72% from its latest closing price compared to the recent 1-year high of $144.78. The company’s stock price has collected -0.62% of loss in the last five ...See details»
Is a Beat on the Cards for Novo Nordisk (NVO) in Q4 Earnings?
Source from : Nasdaq - 2 days ago
Novo Nordisk A/S NVO is scheduled to release its fourth-quarter 2022 results on Feb 1. The company’s earnings surprise history has been good so far, with its earnings beating the Zacks Consensus ...See details»
Novo Nordisk A/S – Share repurchase programme
Source from : Yahoo - 11 days ago
Bagsværd, Denmark, 16 January 2023 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...See details»
Do You Think Novo Nordisk A/S (NVO) is an Economically Sensitive Stock?
Source from : Yahoo! Sports - 16 days ago
Mawer Investment Management highlighted stocks like Novo Nordisk A/S (NYSE:NVO) in the fourth quarter investor letter. Headquartered in Bagsvaerd, Denmark, Novo Nordisk A/S (NYSE:NVO) is a ...See details»
Novo Nordisk A/S:
Source from : Yahoo Finance - 1 month ago
Bagsværd, Denmark, 22 December 2022 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and ...See details»
Novo Nordisk A/S Share Repurchase Programme
Source from : Mena FN - 6 days ago
Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com , facebook , twitter ...See details»
Novo Nordisk A/S:
Source from : Yahoo News Singapore - 1 month ago
Bagsværd, Denmark, 22 December 2022 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and ...See details»